In the majority of cases examined, LAM cells and other PEComas harbour mutations in TSC-2 resulting in constitutive activation of the mechanistic (previously mammalian) target of rapamycin (mTOR)[7], a pivotal cellular kinase controlling growth, metabolism and autophagy[8]. This evidence concerns the gene MTOR and neoplasm with perivascular epithelioid cell differentiation.